Literature DB >> 7588993

Interaction of theophylline and ipriflavone at the cytochrome P450 level.

K Monostory1, L Vereczkey.   

Abstract

The effect of ipriflavone administered at a dose of 25 mg/kg and 100 mg/kg and coadministered with theophylline was investigated in selective assays of particular P450 isoenzyme activities. Significant changes could be detected in the activities of CYP2E1 and CYP3A in liver microsomes from male Wistar rats treated with ipriflavone. Induction of CYP2E1 was shown by aniline or p-nitro-phenol hydroxylation as a result of ipriflavone treatment. Aniline hydroxylation activity of CYP2E1 was induced by theophylline + ipriflavone (100 mg/kg) coadministration as well. It should be noted that theophylline does not cause alteration in CYP2E1 activity. On the other hand, ipriflavone inhibited ethylmorphine and aminopyrine N-demethylation activities catalysed by CYP3A. An additional effect in the inhibition of aminopyrine N-demethylation could be observed in microsomes from theophylline + ipriflavone treated groups. Our results suggest that the decrease in theophylline metabolism increasing level of serum theophylline of theophylline-treated patient during ipriflavone administration [Takahashi J. et al. (1992): Eur. J. Clin. Pharmacol., 43, 207-208] may be related to CYP3A inhibition by ipriflavone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588993     DOI: 10.1007/BF03192287

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  Elevation of serum theophylline levels by ipriflavone in a patient with chronic obstructive pulmonary disease.

Authors:  J Takahashi; K Kawakatsu; T Wakayama; H Sawaoka
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  The utility of p-nitrophenol hydroxylation in P450IIE1 analysis.

Authors:  D R Koop; C L Laethem; D J Tierney
Journal:  Drug Metab Rev       Date:  1989       Impact factor: 4.518

Review 3.  Enzyme induction in the cytochrome P-450 system.

Authors:  A B Okey
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

4.  Flavonoids as inhibitors of rat liver monooxygenase activities.

Authors:  S Beyeler; B Testa; D Perrissoud
Journal:  Biochem Pharmacol       Date:  1988-05-15       Impact factor: 5.858

5.  Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes.

Authors:  T A van der Hoeven; M J Coon
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

6.  p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol.

Authors:  L A Reinke; M J Moyer
Journal:  Drug Metab Dispos       Date:  1985 Sep-Oct       Impact factor: 3.922

7.  Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme.

Authors:  B J Song; H V Gelboin; S S Park; C S Yang; F J Gonzalez
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

8.  Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid.

Authors:  D E Ryan; L Ramanathan; S Iida; P E Thomas; M Haniu; J E Shively; C S Lieber; W Levin
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

9.  Calcitonin secreting property of ipriflavone in the presence of estrogen.

Authors:  I Yamazaki; M Kinoshita
Journal:  Life Sci       Date:  1986-04-28       Impact factor: 5.037

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  1 in total

1.  The effect of ipriflavone and its main metabolites on theophylline biotransformation.

Authors:  K Monostory; L Vereczkey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.